Status:
COMPLETED
Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
This is a clinical study to investigate the safety and efficacy of hylastan in treating patients with symptomatic osteoarthritis (OA) of the knee.
Eligibility Criteria
Inclusion
- Diagnosed with OA of the knee
- Have tried but not been sufficiently helped by conservative treatment, such as weight reduction and pain medications
Exclusion
- Prior or concomitant treatments that would impede measurement of safety and efficacy
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
September 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00139295
Start Date
October 1 2004
End Date
September 1 2007
Last Update
February 5 2014
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
Capstone Clinical Trials, Inc
Birmingham, Alabama, United States, 35209
2
Hope Research Institute, LLC
Phoenix, Arizona, United States, 85050
3
Tucson Orthopedic Institute, PC
Tucson, Arizona, United States, 85712
4
Orthopaedic Specialties of Tampa Bay
Clearwater, Florida, United States, 33756